Monoclonal Antibody Therapy in Parkinson's Disease — The End? | NEJM - nejm.org

8/3/2022 12:00:00 AM2 years 9 months ago

Editorial from The New England Journal of Medicine — Monoclonal Antibody Therapy in Parkinson’s Disease — The End?

From Translational Health Sciences, Bristol Medical School, University of Bristol, and the Movement Disorders Group, Bristol Brain Centre, Southmead Hospital, North Bristol NHS Trust both in Bristol,… [+15 chars]

full article...